RIVERVIEW REGIONAL MEDICAL CENTER
1. Target Overview & Investment Thesis
RIVERVIEW REGIONAL MEDICAL CENTER is a 256-bed suburban community hospital in ETOWAH, AL with $101.5M in net patient revenue and a -3.6% operating margin. The hospital serves a payer mix of 27.9% Medicare, 9.5% Medicaid, and 62.6% commercial.
Thesis: Undervalued. Our ML models identify $7.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.6% to 3.7% (+736bps).
| Net Revenue HCRIS | $101.5M |
| Current EBITDA COMPUTED | $-3.7M |
| Operating Margin COMPUTED | -3.6% |
| Occupancy HCRIS | 31.5% |
| Revenue / Bed COMPUTED | $396K |
| Net-to-Gross HCRIS | 11.0% |
| Distress Probability ML | 53.4% |
2. Market Context & Competitive Position
AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of -3.6% places it above the state median. Among 29 size-comparable peers (128-512 beds), the median margin is -4.8%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (128-512), prioritizing same-state peers. 29 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| RIVERVIEW REGIONAL MEDICAL CEN (Target) | AL | 256 | $101.5M | -3.6% |
| THE CHILDRENS HOSPITAL OF ALAB | AL | 351 | $839.5M | 5.8% |
| GRANDVIEW MEDICAL CENTER | AL | 404 | $615.4M | 14.2% |
| DCH REGIONAL MEDICAL CENTER | AL | 372 | $601.9M | -11.2% |
| BAPTIST MEDICAL CENTER SOUTH | AL | 348 | $595.4M | -4.8% |
| ST VINCENTS BIRMINGHAM | AL | 399 | $480.0M | -5.5% |
| SOUTHEAST HEALTH MEDICAL CENTE | AL | 353 | $427.1M | -4.4% |
| EAST ALABAMA MEDICAL CENTER | AL | 297 | $399.6M | -6.5% |
| USA HEALTH UNIVERSITY HOSPITAL | AL | 242 | $348.5M | -6.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.1M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.0M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.2M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $65K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-3.7M |
| + RCM Uplift | +$7.5M |
| Pro Forma EBITDA | $3.8M |
| Current Margin | -3.6% |
| Pro Forma Margin | 3.7% |
| WC Released (1x) | $3.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-5.7M | $50.4M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-5.7M | $53.6M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-5.1M | $76.5M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-5.1M | $81.9M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-6.2M | $14.9M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-6.2M | $14.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 31.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 53.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 29 hospitals with 128-512 beds
- Same-state prioritization (n=30)
- Comp margins: P25=-9.9% / P50=-4.8% / P75=2.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.